Dabur India Ltd

Dabur India Ltd

₹ 482 1.03%
23 May - close price
About

Dabur is India’s leading FMCG, Ayurvedic and natural health care companies with wide network distribution across world. [1]

Key Points

Leading FMCG Company Dabur India Limited is the fourth largest FMCG Company in India and the world’s largest Ayurvedic and Natural Health Care Company with a portfolio of over 250 Herbal/Ayurvedic products.[1]

  • Market Cap 85,417 Cr.
  • Current Price 482
  • High / Low 672 / 420
  • Stock P/E 60.9
  • Book Value 41.9
  • Dividend Yield 1.14 %
  • ROCE 24.6 %
  • ROE 19.6 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 77.6%

Cons

  • Stock is trading at 11.5 times its book value
  • The company has delivered a poor sales growth of 7.53% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,852 2,180 2,267 2,298 1,939 2,347 2,334 2,414 2,039 2,514 2,144 2,448 1,965
1,523 1,752 1,794 1,801 1,636 1,885 1,826 1,883 1,703 2,017 1,740 1,926 1,680
Operating Profit 329 428 473 497 304 462 509 532 337 497 403 523 284
OPM % 18% 20% 21% 22% 16% 20% 22% 22% 16% 20% 19% 21% 14%
92 84 108 86 85 99 102 102 114 110 118 105 119
Interest 7 7 8 13 19 15 18 24 23 19 29 28 23
Depreciation 41 44 47 48 50 51 51 52 54 60 64 64 63
Profit before tax 374 461 526 522 320 495 542 557 373 527 429 536 317
Tax % 22% 24% 25% 24% 27% 24% 22% 23% 24% 23% 23% 22% 21%
292 350 396 394 233 378 420 428 283 405 329 418 251
EPS in Rs 1.65 1.98 2.23 2.23 1.32 2.13 2.37 2.42 1.60 2.29 1.86 2.36 1.41
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
4,860 5,420 5,340 5,291 5,592 6,273 6,310 7,185 8,180 8,684 9,136 9,071
4,034 4,480 4,242 4,178 4,360 4,906 4,927 5,626 6,445 6,984 7,295 7,364
Operating Profit 826 940 1,098 1,112 1,232 1,367 1,383 1,559 1,734 1,701 1,840 1,707
OPM % 17% 17% 21% 21% 22% 22% 22% 22% 21% 20% 20% 19%
108 112 194 274 266 275 175 277 341 363 416 452
Interest 19 10 10 16 22 30 19 9 19 46 81 100
Depreciation 54 66 73 75 102 109 130 143 160 188 209 251
Profit before tax 861 977 1,209 1,294 1,373 1,503 1,408 1,683 1,896 1,829 1,967 1,808
Tax % 22% 22% 22% 23% 22% 16% 17% 18% 24% 25% 23% 22%
672 763 937 998 1,072 1,264 1,170 1,382 1,433 1,373 1,509 1,403
EPS in Rs 3.85 4.34 5.33 5.67 6.09 7.16 6.62 7.82 8.11 7.75 8.52 7.92
Dividend Payout % 45% 46% 42% 40% 123% 38% 45% 61% 64% 67% 65% 101%
Compounded Sales Growth
10 Years: 5%
5 Years: 8%
3 Years: 4%
TTM: -1%
Compounded Profit Growth
10 Years: 6%
5 Years: 3%
3 Years: -1%
TTM: -7%
Stock Price CAGR
10 Years: 6%
5 Years: 2%
3 Years: -1%
1 Year: -14%
Return on Equity
10 Years: 26%
5 Years: 23%
3 Years: 22%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 174 176 176 176 176 177 177 177 177 177 177 177
Reserves 1,728 2,161 2,918 3,482 4,051 3,792 4,398 5,214 5,687 6,110 6,738 7,246
44 129 87 284 287 310 151 180 560 615 776 379
1,175 1,223 1,248 1,275 1,299 1,300 1,375 1,933 2,168 2,450 2,841 3,203
Total Liabilities 3,122 3,688 4,430 5,217 5,813 5,579 6,100 7,504 8,592 9,352 10,533 11,005
654 683 639 993 1,030 1,037 1,134 1,205 1,399 1,662 1,878 2,038
CWIP 17 12 25 28 27 22 106 107 128 109 184 135
Investments 1,118 1,778 2,570 3,054 3,433 2,962 2,467 3,574 5,007 5,475 6,148 6,359
1,333 1,215 1,196 1,141 1,322 1,558 2,393 2,618 2,057 2,106 2,322 2,474
Total Assets 3,122 3,688 4,430 5,217 5,813 5,579 6,100 7,504 8,592 9,352 10,533 11,005

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
712 839 960 927 816 1,124 1,155 1,704 1,320 1,562 1,653 1,623
-98 -613 -494 -679 -261 418 -330 -1,120 -682 -617 -736 -99
-535 -337 -455 -274 -496 -1,619 -826 -555 -635 -940 -922 -1,511
Net Cash Flow 79 -111 11 -26 59 -78 -2 29 3 5 -5 13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 24 23 29 23 21 25 22 14 20 24 29 24
Inventory Days 109 94 106 103 117 106 120 141 132 118 109 95
Days Payable 137 130 160 157 159 145 153 187 169 176 195 172
Cash Conversion Cycle -4 -13 -25 -31 -21 -13 -11 -32 -16 -34 -58 -53
Working Capital Days -5 -4 -1 -7 1 -8 0 -17 -10 -16 -23 32
ROCE % 46% 45% 42% 37% 33% 35% 34% 33% 32% 28% 28% 25%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
67.24% 67.23% 66.23% 66.23% 66.23% 66.24% 66.25% 66.26% 66.25% 66.25% 66.27% 66.28%
20.23% 20.24% 20.47% 19.73% 19.39% 18.37% 16.49% 15.82% 14.99% 15.05% 13.28% 12.68%
4.04% 6.57% 7.48% 8.31% 8.75% 9.78% 11.66% 12.46% 13.45% 13.57% 14.85% 15.62%
0.00% 0.06% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07%
8.50% 5.89% 5.74% 5.65% 5.57% 5.53% 5.54% 5.40% 5.26% 5.07% 5.53% 5.36%
No. of Shareholders 4,83,5604,57,4904,43,6184,48,9754,44,8324,33,5014,39,1234,34,8234,35,2134,30,4365,10,2985,05,557

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls